Francesco Antonio Naro Di

Biography

Antonio Francesco Di Naro (born in 1966) is Chairman and President. He holds a doctor in chemistry and pharmaceutical technologies and developed two transplantation products (Thymoglobuline and Celsior). He has more than 20 years’ experience in the development of orphan drugs from reasearch to commercialization. He began his career as a teacher at vocational schools of Bergamo (Italy) from 1986 to 1989. From 1989 to 1992, he worked as researcher at the Pharmacology Laboratory of Research Institute Mario Negri (Italy). He joined Janssen Pharmaceutical Spa (Italy) where he was employed as a sales manager from 1992 to 1994. Antonio Francesco Di Naro (born in 1966) is Chairman and President. He holds a doctor in chemistry and pharmaceutical technologies and developed two transplantation products (Thymoglobuline and Celsior). He has more than 20 years’ experience in the development of orphan drugs from reasearch to commercialization. He began his career as a teacher at vocational schools of Bergamo (Italy) from 1986 to 1989. From 1989 to 1992, he worked as researcher at the Pharmacology Laboratory of Research Institute Mario Negri (Italy). He joined Janssen Pharmaceutical Spa (Italy) where he was employed as a sales manager from 1992 to 1994.

Research Interest

From 1994 to 1996 he moved to Pasteur Mérieux S.r.l. (Italy) where he worked as general manager. From 1996 to 1998, he began to work as general manager at IMTIX (Italy) and Corporate Director South Europe at IMTIX (France). From 1998 to 2003 he joined SangStat, where he was active in different functions (CEO and general manager; vice president Europe and International). From 2003 to 2004, he was employed as a vice president Europe and International of Genzyme. From 2004, he was co-founder of OPi Pharma and he founded DICRAM SA, ADIENNE S.r.l., ADIENNE SL, ADIENNE SA and the Company.